Fri 23'rd Feb 2018
Iovance Biotherapeutics, Inc. Stock Analysis
Technical stock analysis for Fri 23'rd Feb 2018
|Shorts||3.26% ( 2018-01-31 )|
Iovance Biotherapeutics, Inc. lies in the upper part of a very wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $19.21 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 138.76% during the next 3 months and, with 90% probability hold a price between $35.27 and $45.87 at the end of this period.
Only positive signals in the chart today. Iovance Biotherapeutics, Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $17.88 and $13.78. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday February 20, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
The stock holds a RSI14 at 74 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
Support & Resistance
Iovance Biotherapeutics, Inc. finds support from accumulated volume at $18.50. There is no resistance from accumulated volume above today's level and given the right condition the stock may perform very well during the next couple of days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.85 between high and low, or 17.54%. For the last week, the stock has had a daily average volatility of 8.46%.
The stock is overbought on RSI14 and lies in the upper part of the trend. Normally this will pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stoploss: $18.26 (-3.92%) (This stock has high daily movements and this gives high risk. The RSI14 is 74 and this increases the risk substantially. There is a buy signal from pivot bottom found 3 days ago.)
Very Low Low Medium High Very High
Iovance Biotherapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Trade IOVA CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder